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In vitro anti-HCV activities of Saxifraga melanocentra and its related polyphenolic compounds
Guo-Ying Zuo, Zheng-Quan Li, Li-Rong Chen and Xiao-Jie Xu* College of Chemistry and Molecular Engineering, Yashentang Nature Medicine Laboratory, Peking University, Beijing, China *Corresponding author: Tel: +86 10 6275 7456; Fax: +86 10 6275 1708; E-mail: xiaojxu@chem.pku.edu.cn Hepatitis C virus (HCV) infection is a major cause of chronic liver disease which infects more than 170 million people (three times the figure infected with HIV) worldwide (De Francesco et al., 2003) , often leading to liver cirrhosis, hepatic failure and hepatocellular carcinoma. The current approved therapy is confined to interferon (INF-α) and ribavirin, but the overall chances of a cure for patients are less than 50%, and there is still no preventive vaccine available. Hence there remains the urgent need to find additional therapeutic agents.
HCV is an enveloped virus with positive-strand RNA genome encoding a polyprotein. The polyprotein is cleaved by NS3 serine protease at four junctions (NS3/NS4A, NS4A/NS4B, NS4B/NS5A and NS5A/NS5B) in the nonstructural part of this protein, where NS4A is a cofactor of the protease. As the NS3/4A protease has been wellcharacterized biochemically, and the crystal structure has been solved by several groups, it becomes a valid target for developing new therapies of HCV infection (De Francesco et al., 2003) . However, chemical entities as inhibitors of HCV NS3 serine protease have been studied mainly on synthetic compounds. Natural plant products are an enormous bank of chemical and biological diversity. Many compounds in herbal medicines, especially polyphenolic compounds, have been proven to have antiviral properties, such as anti-HIV and herpes (Vlietinck et al., 1998) . Knowledge about these types of compounds on HCV NS3 serine protease is limited (Hegde et al., 2003) .
As a program of our continuing efforts to discover naturally-occurring new anti-HCV agents, we have screened over one hundred extracts from Chinese medicinal herbs for HCV NS3 protease inhibitors (Duan et al., 2004) . We report herein on the bioactive-guided isolation and identification of HCV NS3 protease inhibitory compounds from Saxifraga melanocentra Franch.
Introduction
The aim of this study was to search for new natural anti-HCV agents from Chinese herbal medicine. Bioactivity-guided extraction and isolation methods were used. Active part and pure compounds were obtained from ethanolic extract of Saxifraga melanocentra Franch. and their in vitro inhibitory activities (IC 50 ) against HCV NS3 serine protease were tested by enzyme-linked immunosorbent assay. Results showed that the polyphenolic ethyl acetate part of the herbal extract was the most active, and from this 18 polyphenols representing active compounds were isolated and identified. IC 50 values of these compounds and five related ones were obtained. SiMe 4 as internal standard; chemical shifts are given as ppm values. IR spectra were recorded on a Nicolet Magana-IR750 (Nicolet Instrument Inc., Madison, WI, USA). Electrospray ionization and time of flight mass spectra (ESI-TOF-MS) were taken on a Mariner Biospectrometry workstation (Perseptive Biosystems Inc., MA, USA). TLC plates were made with polyamide film (China), and spots were detected by ultraviolet (UV) and by spraying with 5% ethanolic FeCl 3 reagent. Polyamide (100-200 mesh, China) and Sephadex. LH-20 (Amersham Pharmacia Biotech, Piscataway, NJ, USA) were used for column chromatography (CC). The organic solvents used were of analytical grade. Solvents in the extracts were evaporated under reduced pressure at below 40°C.
Expression and purification of HCV NS3 protease domain
The constructed pMANS34NsH expression plasmid containing MBP-NS3 serine protease-His6 was transformed into E.coli JM109. HCV NS3 protease domain was expressed and purified following the procedure described in literatures (Duan et al., 2004) .
NS3 serine protease activity assay
The assays of NS3 serine protease activity were conducted by Enzyme-Linked Immunosorbent Assay (ELISA) according to the reported method (Duan et al., 2004) . For the inhibitory activities of sample compounds, aliquots of each sample 10 mg/ml (DMSO) were diluted to 1.0, 0.1, 0.01, 0.001 mg/ml (DMSO), respectively. Peptide substrate, NS3 serine protease and inhibitor were added and incubated at 37°C for 15 min. 
Extraction and partition of the extract between water and organic solvents
The aerial parts of S. melanocentra were obtained from the Qinghai Institute of Tibetan Medicines (Qinghai Province, China) where a voucher specimen has been deposited.
The powdered aerial part of S. melanocentra (1 kg) were extracted with ethanol (80%, 4 l ×3) at room temperature and concentrated to dryness in vacuo to give a crude extract (205 g). The extract was partitioned between H 2 O (600 ml) and petroleum ether (60-90 o C), chloroform, ethyl acetate and n-butanol (250 ml ×3 each) successively. The organic layers were concentrated to dryness in vacuo and subjected to bioassay, respectively.
Removal of macro molecular tannins from the active extract
The macro molecular tannins were removed by passing the extract through a polyamide resin column. The active constitution of molecular weight below 1000 was eluted from the column with 80% acetone (H 2 O) (Collins et al., 1998) .
Isolation and identification of active compounds
The polyamide resin column-treated ethyl acetate part (20 g), having the most potent inhibitory activity for HCV NS3 serine protease by about 80% at 100 mg/ml, was fractionated over a silica gel CC with solvent systems as ethyl acetate-methanol-H 2 O (10:1:0~7:1.5:1) to give two active fractions (Frs-1 and 2) (Figure 1) .
To obtain further information on the inhibitory activity for HCV NS3 serine protease, the less active fraction (Fr-2, 5.0 g) was also subjected to CC on a silica gel column (ethyl acetate-methanol- 
Other compounds assayed
Cytotoxicity assay
Cos7 cells were cultured in DMEM medium and transfected with recombinant plasmid DNA following the protocol in literature (Mao et al, 2003) . Cell suspensions (0.2 ml of 2x10 4 cells/ml) were prepared in a 96-multi-well plate and incubated at 37 o C in an atmosphere of 5% CO 2 overnight. Drug-containing medium (0.2 ml, containing compounds [1] and [3], respectively) at five concentrations (2-6 mg/ml) was added to the cell culture, and the blank (DMSO) and positive control were treated with medium containing equivalent concentrations, respectively. After 24 h of incubation, 0.01 ml of MTT was added to each well and the culture was incubated for a further 4 h. The number of surviving cells was counted by the MTT method. The activity of the mitochondria, reflecting cellular growth and viability, was evaluated by measuring the optical density (OD) of each well at 570 nm, using an
In vitro anti-HCV activities of Saxifraga melanocentra MRX multiwell spectrophotometer (USA). The cytoxicity index (CI%) was calculated according to the equation CI%=[1-(T/C)]×100%, where T and C represent the mean optical density of the treated group and vehicle control group, respectively. Accordingly, the CI% of the doseresponse curve was drawn with Origin Pro 7.0 (OriginLab, USA) (Figure 2) . All experiments were repeated at least three times.
Results
In the course of our screening program for HCV NS3 serine protease inhibitors from natural resources, we found that the 80% aqueous ethanol extract of aerial parts of S. melanocentra had promising inhibitory activity against HCV NS3 serine protease. Subsequent tracking of the extract was performed by extracting the water-suspended . All these compounds were known and were identified according to literatures (Tanaka et al., 1985; Haddock et al., 1982; Ahn et al., 1996; Yasuo et al., 1995) .
The 18 isolated pure polyphenols in the ethyl acetate part and five purchased related compounds were tested by ELISA method. IC 50 values of these compounds were obtained. They show a broad-degree of anti-HCV activities ( 
Discussion
In this paper, we reported the anti-HCV activities of 18 polyphenols isolated from S. melanocentra and five related compounds for the first time (Figure 1 ). Bioactivitydirected screening of the active parts and the assay of pure compounds inhibiting against HCV NS3 serine protease were performed through ELISA method (Tables 1 and 2) .
From the results of these experiments, it was found that the inhibitory activities against HCV NS3 serine protease were in the following order: tannins > flavonoids > phenolic acids. The strongest inhibitory compounds were multigallated esters of D-glucose, The tested Cos 7 cells were transfected with recombinant plasmid DNA (Mao et al., 2003) and their cell activity were determined by MTT method. The value of 1.0 on ordinate represented the vehicle cell activity which was unaffected, and also under the concentration of the drugs at 1.0 mg/ml or more, other values were in comparison with the vehicle. Flavonoids had moderate to weak activity in the range of 33.11-370.37 µM, with the exception of 2′′-O-galloyl-rutin (4.86 µM). Gallic acid and its methyl and ethyl esters, Bergenin and others showed the potency of activity only in a number of mM. The commercial compounds DDB and Bicyclol, which have been used in China to treat chronic hepatitis B (Wong, 2001) , together with ribavirin and chlorogenic acid had little activity on HCV NS3 serine protease. For ribavirin, with a different mode of action on HCV, its low inhibitory activity against NS3 serine protease is reasonable. Mention should also be made of the acetylated derivatives of compound [5a] which showed increased potency of inhibition compared with [5], but further information needs to be obtained.
To evaluate the cytotoxic effect of the compounds, two of the most active compounds, [1] and [3] were tested against transfected Cos 7 cells. The results revealed these compounds had little cytotoxicity against the tested cells (Figure 2) . Still, the selectivity of these compounds needs subsequent investigation.
In conclusion, polyphenols were responsible for the anti-HCV constitution of S. melanocentra. And multigallated esters of D-glucose possessed strongest inhibition against HCV NS3 serine protease, suggesting the potential use of these compounds for designing and developing drugs in the treatment of this viral infection.
